Abstract
Magnetotactic bacteria (MTB), possessing chains of iron oxide nanoparticles, are potential tools for controlled therapy due to their responsiveness to weak magnetic fields. This study aims to evaluate the targeting and aggregation capabilities of axial AMB-1 and polar MO-1 MTB for therapeutic applications. A three-dimensional focusing magnetic field (fMF)-producing device was designed and established with a gradient magnetic field of 0.08 mT/mm at the central region for the guidance of MTB in vitro and in vivo. Under a unidirectional magnetic field, polar Magneto-ovoid MO-1 formed a single line in the culture dish, whereas axial Magnetospirillum magneticum AMB-1 displayed a small portion aggregated on the centerline. With simultaneous X and Y magnetic field application, MO-1 cells aggregated at a point, while AMB-1 bacteria gathered incompletely. Further, magnetic resonance imaging of breast cancer-bearing nude mice injected subcutaneously with MTB peritumorally and navigated by a fMF revealed more substantial aggregation of MO-1 cells within the tumor than AMB-1 bacteria. Prussian blue staining corroborated the penetration of MO-1 cells into the tumor tissue. These findings suggest that polar MO-1 bacteria exhibit superior targeting and aggregation properties compared to axial AMB-1, indicating their potential suitability for targeted therapeutic applications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
